[Therapeutic effect of progesterone-bis-guanylhydrazone on rat mammary tumors and on the mouse in comparison to triaziquone (Trenimon) and cyclophosphamide].
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006571:Heterocyclic Compounds / Q000627:therapeutic use* / Q000633:toxicity; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D011374:Progesterone / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D014228:Triaziquone / Q000627:therapeutic use*
D006571:Heterocyclic Compounds; D011374:Progesterone; D003520:Cyclophosphamide; D014228:Triaziquone
Therapeutischer Effekt von Progesteron-bis-guanylhydrazon an Geschwülsten der Rattenmamma und an der Maus im Vergleich zu Triaziquon (Trenimom) und Cyclophosphamid.